NDC 70436-149-33 - methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70436-149
- Requested NDC
- 70436-149-33
- Package NDCs from labels
- 70436-149-33, 70436-149-55
- Manufacturer
- Slate Run Pharmaceuticals, LLC | Hainan Poly Pharm Co., Ltd.
- Effective date
- 2024-06-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| methocarbamol injection, usp | Slate Run Pharmaceuticals, LLC | Hainan Poly Pharm Co., Ltd. | 2024-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70436-149-33 | methocarbamol | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 10 | 1 | |
| 70436-149-55 | methocarbamol | 25 in 1 CARTON | INJECTION | 25 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | Advanced Rx of Tennessee, LLC | 4b1d8ac6-d25d-1c37-e063-6394a90aba29 | 2026-02-18 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 288a3bcd-a2c8-4a9b-9602-59c0493b4a8d | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 3b0e60a7-3cff-4665-a473-ad3257619cdd | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 943fe701-5d7d-4abe-a529-c5a548e94bc6 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 440bf1ba-a704-4c35-bece-0a0987fc0c11 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 12c8da39-3a0e-4303-9655-29dd83507837 | 2026-02-16 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 4abc29e9-a0cc-06cf-e063-6294a90ad874 | 2026-02-13 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Major Pharmaceuticals | 2df34fa7-9cdc-4be4-ac6f-577122462606 | 2026-02-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bostal LLC | d8f10211-f96e-4cf3-9b49-986eb51b703d | 2026-02-04 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-01-30 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | UNICHEM PHARMACEUTICALS (USA), INC. | 5777cbb0-b5fd-4b36-ac1d-bc105fe96888 | 2026-01-19 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed95-0469-393a-e053-2a95a90a98ed | 2026-01-19 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | NuCare Pharmaceuticals,Inc. | 36c2c31c-8648-7723-e063-6294a90aec98 | 2026-01-14 | Warnings, Adverse reactions | 125OD7737X |
| Endotoxin Terrain Drops 2143 | ENDOTOXIN TERRAIN DROPS | Professional Complementary Health Formulas | 58842566-005a-48b5-973d-20cde2fbd701 | 2026-01-08 | Warnings | QTT17582CB |
| METHOCARBAMOL | METHOCARBAMOL | DIRECT RX | 31508051-c9cb-149b-e054-00144ff88e88 | 2026-01-08 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | AvPAK | be37bc85-6a41-00d8-e053-2a95a90ae504 | 2026-01-08 | Warnings, Adverse reactions | 125OD7737X |
| Abdominal Pain Drops 2051 | ABDOMINAL PAIN DROPS | Professional Complementary Health Formulas | f1b1dde6-bb37-4774-a58c-b4f648f9c2b5 | 2026-01-08 | Warnings | QTT17582CB |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed5f-3489-9ee4-e053-2995a90a25f0 | 2026-01-01 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Northwind Health Company, LLC | f31ccb09-7a9a-60af-e053-2995a90a6e97 | 2026-01-01 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Northwind Health Company, LLC | df63611f-90e4-6bbe-e053-2a95a90a2aad | 2026-01-01 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.